AstraZeneca PLC (ZEGA) — Capital Reinvestment Ratio
AstraZeneca PLC (ZEGA) has a Capital Reinvestment Ratio of 0.34x as of September 2025, meaning it reinvests 0% of its operating cash flow (€5.13 Billion) in capital expenditures (€1.73 Billion). See ZEGA net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AstraZeneca PLC Capital Reinvestment Ratio (2014–2024)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 11 annual periods. Check total reinvestment intensity of AstraZeneca PLC to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (2014–2024)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 2014 to 2024. For live market cap and broader valuation context, see how much is AstraZeneca PLC worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | €11.86 Billion | €4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | €10.36 Billion | €3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | €9.81 Billion | €1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | €5.96 Billion | €1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | €4.80 Billion | €961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | €2.97 Billion | €979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | €2.62 Billion | €1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | €3.58 Billion | €1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | €4.14 Billion | €2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | €3.32 Billion | €1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | €7.06 Billion | €1.01 Billion | — |